As we have written about here and on our sister blog, Ad Law Access, regulators have wasted no time in taking enforcement actions against companies’ alleged false marketing around COVID-19. Just today, the Office of the New York Attorney
Continue Reading New York Joins the CBD COVID-19 Enforcement Fray
COVID-19 Regulatory
CBD Manufacturer Not Immune From FDA Enforcement For COVID-19 Claims
By Lauren Myers on
In the midst of continued enforcement regarding coronavirus marketing, FDA sent a warning letter to NeuroXPF concerning advertising for its CBD products alleging that they can boost immune systems to help consumers avoid contracting the virus. Citing the need to…
Continue Reading CBD Manufacturer Not Immune From FDA Enforcement For COVID-19 Claims